Indoor Microbiome and The Rising Asthma Prevalence

Xi Fu, Yu Sun
{"title":"Indoor Microbiome and The Rising Asthma Prevalence","authors":"Xi Fu, Yu Sun","doi":"10.33590/microbiolinfectdis/19-00190","DOIUrl":null,"url":null,"abstract":"The prevalence of asthma has increased in the past few decades in most developed and developing countries. Large-scale, cross-sectional epidemiological studies have reported several factors associated with asthma prevalence and severity, including parental asthma, tobacco smoking, preterm delivery, virus infection, and air pollution. However, a puzzling problem is that the time trends in the prevalence of these risk factors cannot explain the rise in asthma. For example, the prevalence of smoking and clinical pneumonia have been decreasing globally in the past few decades. Recent progress in high-throughput sequencing technology has promoted the progress of microbiome research and established associations between human and indoor microbiomes, and many metabolic, cognitive, and immune diseases including asthma and allergies. In this review, the authors systematically summarise the current literature, standard practice, and analysis pipeline in the field of indoor microbiome and asthma. The strength and limitation of different analytical approaches are discussed, including the utilisation of relative and absolute abundance in the associated studies. The authors discuss new frameworks of integrated microbiome research from different ecological niches, functional profiling from multiomics data, and how these new insights can facilitate understanding of asthma mechanisms and even the development of new personalised treatment strategies for the rising asthma epidemic.","PeriodicalId":72900,"journal":{"name":"EMJ. Microbiology & infectious diseases","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"2020-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"EMJ. Microbiology & infectious diseases","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.33590/microbiolinfectdis/19-00190","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

The prevalence of asthma has increased in the past few decades in most developed and developing countries. Large-scale, cross-sectional epidemiological studies have reported several factors associated with asthma prevalence and severity, including parental asthma, tobacco smoking, preterm delivery, virus infection, and air pollution. However, a puzzling problem is that the time trends in the prevalence of these risk factors cannot explain the rise in asthma. For example, the prevalence of smoking and clinical pneumonia have been decreasing globally in the past few decades. Recent progress in high-throughput sequencing technology has promoted the progress of microbiome research and established associations between human and indoor microbiomes, and many metabolic, cognitive, and immune diseases including asthma and allergies. In this review, the authors systematically summarise the current literature, standard practice, and analysis pipeline in the field of indoor microbiome and asthma. The strength and limitation of different analytical approaches are discussed, including the utilisation of relative and absolute abundance in the associated studies. The authors discuss new frameworks of integrated microbiome research from different ecological niches, functional profiling from multiomics data, and how these new insights can facilitate understanding of asthma mechanisms and even the development of new personalised treatment strategies for the rising asthma epidemic.
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
室内微生物群与哮喘患病率上升
在过去几十年中,大多数发达国家和发展中国家的哮喘患病率有所增加。大规模、横断面流行病学研究报告了与哮喘患病率和严重程度相关的几个因素,包括父母哮喘、吸烟、早产、病毒感染和空气污染。然而,一个令人困惑的问题是,这些危险因素流行的时间趋势并不能解释哮喘发病率的上升。例如,在过去几十年中,全球吸烟和临床肺炎的患病率一直在下降。高通量测序技术的最新进展促进了微生物组研究的进展,并建立了人体和室内微生物组与许多代谢、认知和免疫疾病(包括哮喘和过敏)之间的联系。本文系统综述了室内微生物组与哮喘的相关文献、标准实践和分析进展。讨论了不同分析方法的强度和局限性,包括在相关研究中相对丰度和绝对丰度的利用。作者讨论了来自不同生态位的综合微生物组研究的新框架,来自多组学数据的功能分析,以及这些新见解如何促进对哮喘机制的理解,甚至为不断上升的哮喘流行制定新的个性化治疗策略。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
自引率
0.00%
发文量
0
期刊最新文献
ECCMID 2023 Abstract Highlights Clostridioides difficile Infection: Targeting an Unwelcome and Persistent Threat SARS-CoV-2 Pandemic and Neisseria meningitidis Serogroup B Invasive Infections: Insights From Italian Surveillance Data and Vaccination Rates Providing Expert Consultation in a World Living with COVID-19 Interview: Anne L. Wyllie
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1